Fresenius Medical Care AG (FMS) Depreciation & Amortization (CF) (2009 - 2025)

Fresenius Medical Care AG (FMS) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $434.2 million in Q4 2025.

• In Q4 2025, Depreciation & Amortization (CF) fell 14.82% year-over-year to $434.2 million; the TTM figure through Dec 2025 stood at $1.7 billion (down 10.12% YoY), while the FY2025 annual figure was $1.7 billion, down 6.25% from the prior year.
• Depreciation & Amortization (CF) rose to $434.2 million in Q4 2025, from $417.7 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $556.2 million in Q1 2024 and bottomed at $400.9 million in Q3 2024.
• A 5-year average of $466.1 million and a median of $470.2 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) dropped 27.83% — and 2024, when it increased 18.31%.
• Year by year, Depreciation & Amortization (CF) stood at $499.9 million in 2021, then climbed by 1.02% to $505.0 million in 2022, then slipped by 9.24% to $458.4 million in 2023, then gained by 11.21% to $509.7 million in 2024, then decreased by 14.82% to $434.2 million in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $434.2 million (Q4 2025), $417.7 million (Q3 2025), and $425.6 million (Q2 2025), per Business Quant data.

Peer Comparison